Experimeats were performed to study the cellular mechanism of endothelium-derived relaxing factor (EDRF) on vascular smooth muscle. Rat femoral arteries were cannulated and pressurized to 100 mm Hg. Vascular smooth muscle membrane potential (E m ) and diameter responses to perfusion with 5xlO~6 M acetyicholine (ACh) were measured in vessels precontracted with 5xlO" 6 M norepinephrine (NE). Hyperpolarization (-35 ±1.2 to -66±2.0 mV) and dilation were observed during ACh administration. Both responses were abolished on removal of the endothelium with collagenase. A bioassay was developed in which two vessel segments from the same artery were connected in series. The downstream vessel was deendothelialized while the endothelium of the upstream vessel remained intact. The protocol used was the same as in the first set of measurements. Hyperpolarization and dilation were observed in both vessels during ACh perfusion. However, when the direction of the perfusate flow in the bioassay system was reversed so that the deendothelialized vessel was upstream, only the "endothelium-intact" vessel demonstrated vascular smooth muscle hyperpolarization. To examine the ionic mechanism underlying the hyperpolarization presumably by released EDRF, the E m was measured as a function of increasing extracellular potassium ([K + ] o ). In the presence of ACh (but not NE) the maximum depolarization produced by a decade increase of [K + ] o (10-100 mM) was 50 mV. In the deendothelialized vessel, this depolarization was decreased significantly to 39 mV. Addition to the superfusate of 10 mM tetraethylammonium, a K channel blocker, significantly reduced the hyperpolarization caused by ACh-induced EDRF release. In conclusion, this bioassay represents a useful method for measuring the biomechanical and electrophysiological effects of EDRF. In addition, the data obtained using this methodology support the hypothesis that the EDRF-induced hyperpolarization is mediated, at least in part, by an increase in
I t is now well-documented that factors that inhibit vascular muscle contraction can be released from vascular endothelial cells in response to a variety of agents. 1 -3 Such endothelium-derived relaxing factor(s) (EDRF) have been demonstrated in most blood vessels studied in this regard 4 -6 ; however, very little is known about its cellular mechanism of action.
It has been reported recently that EDRF hyperpolarizes arterial muscle, suggesting a voltagedependent mechanism that mediates vascular relaxation. 7 -8 The membrane ionic mechanisms that have been suggested thus far to account for a possible "EDRF-induced" hyperpolarization of vascular muscle are an increased K + conductance (g K ) and stimulation of Na,K-ATPase. Given the ubiquitous presence of EDRF within various types of blood vessel and, consequently, its potential physiological importance, it is essential to understand its cellular mode of action.
The purpose of the present study is to clarify the cellular and ionic mechanisms of action of EDRF released by acetyicholine (ACh) using an arterial preparation exposed to physiological levels of transmural pressure. To assure that the electrical and mechanical effects of ACh are due to release of endothelial substances and not to ACh itself, a "bioassay" system was designed in which two arterial segments were connected and pressurized in series with only the upstream vessel having an intact endothelium.
Materials and Methods
Femoral arteries were removed from sodium pentobarbital (50 mg/kg) anesthetized male Sprague-pressure reservoir -.
. endothelium smooth muscle smooth muscle FIGURE 1. Drawing of double-perfused femoral artery preparation used in these studies. Upstream vessel (left side) contains an intact endothelium while the downstream vessel (right side) is denuded of endothelium via collagenase perfusion. Pressure transducer monitors transmural pressure (maintained at 100 mm Hg) while the micrometer is used to adjust the vessels to their in vivo length. This is the preparation used to obtain the data illustrated in Figures 4, 5, 6, and 8. Dawley rats weighing 300-350 g. Arterial segments were placed in an organ bath maintaining solutions at 37° C, suffused and perfused with a gasequilibrated (95% O 2 +5% CO 2 ) and pH-regulated (7.4) physiological salt solution containing (mM) Na + 141, C\~ 125, Ca 2+ 2.5, K + 4.7, MgT 0.76, H 2 PO 4 -1.7, HCO 3 -25, glucose 11, ./V-2-hydroxyethylpiperazine-A r '-2-ethanesuh c onic acid (HEPES) 5. The experimental design consisted of two protocols. In the first a single 8-10 mm segment of femoral artery was cannulated at both ends with polyethylene cannulae. The inflow end was fixed and attached to a pressure reservoir in series with a pressure transducer. The outflow cannula was connected to a micrometer to provide adjustment of the arterial length to that in vivo. Using this system, pressure within the vessel could be adjusted to any desired level. The outflow cannula could be clamped to form a blind sack or could be left patent to allow flow through the vessel. Electrical and mechanical measurements were then taken on femoral arteries with an intact endothelium and on the same vessel after endothelial removal. The endothelium was removed by perfusing the system with collagenase (1.0 mg/ml) as previously described. 6 The suffusion solutions contained 5 x 10~ M norepinephrine (NE) to maintain a fixed level of tone. Electrical and mechanical measurements were taken before and after luminal perfusion with 5xlO~ M ACh. Tetraethylammonium (TEA; 10 mM) was added to the bathing solutions in some experiments to block K + channels.
In the second protocol, two femoral arterial segments were connected in series. The inflow segment had an intact endothelium, while the outflow segment was denuded of endothelium ( Figure 1 ). In this preparation, membrane potential (En) and diameter responses to ACh perfusion were recorded in both vessels, first with perfusate directed through the segment with an intact endothelium. Using such an approach, we could easily determine if the response we observed on ACh perfusion was due to release of endothelial factors and could directly examine their mode of action. All solutions and environmental conditions were identical in both protocols. E,,^ were measured by use of glass microelectrodes filled with 3 M KC1 and with tip resistances of 50-80 Mf t and tip potentials of less than 4 mV. The primary criteria for a successful impalement were a sharp drop in voltage from baseline on entry of the microelectrode tip into the cell and a sharp return to zero on exit. 10 Flow through the system was halted (1-5 minutes) to provide an easier cell impalement during En measurement.
The effect of manipulating extracellular potassium ([K + ] o ) on the E,,, of denuded arterial segments receiving flow from upstream arterial segments with intact endothelium was measured both in the presence and absence of ACh. In this manner, E,,, Vessel dimensions were measured using a video monitoring system consisting of a camera (RCA), TVA monitor (Sony), a VCR (Panasonic), and a video dimension analyzer (Colorado Video). Viewing screen magnification was X75. This system was calibrated with a filar micrometer to an accuracy of ±2 fun. Figure 2 demonstrates that superfusion with 5xlO~6 M NE resulted in a 42±6 pm reduction in diameter as compared with controls in physiological saline solution at 100 mm Hg. Control diameter was 777'±26 /xm at 100 mm Hg. ACh perfusion (5x10"* M) dilated these precontracted vessels by 97 ±8 (Figure 2 ). After endothelial removal, the vessel response to NE superfusion was not significantly different from the intact vessels. However, ACh no longer dilated these denuded arteries.
Results

Effects ofACh Perfusion on Intact Femoral Arteries
The electrophysiological correlates to the above are given in Figure 3 . The resting membrane potential of the smooth muscle cells from the rat femoral artery at an intraluminal pressure of 100 mm Hg was -43±1.5 mV. NE significantly depolarized these cells to -35±1.2 mV^ On perfusion with 5 x 10" 6 M ACh, the vascular muscle cells hyperpolarized to -66±2.0 mV, a difference of 31 mV. Enzymatic removal of the endothelium produced no changes in the resting membrane potential or NEinduced depolarization. However, ACh no longer caused hyperpolarization when the vessel was denuded ( Figure 3 ).
In five experiments, indomethacin (10~5 M) was added to the bath. No change in membrane potential was observed, and the response to ACh was not affected (data not shown). Figure 4 shows the mean diameter changes of the recipient vessel in this bioassay. Vessel B was isolated and studied initially in a single vessel experiment as above. This vessel demonstrated dilation with ACh perfusion as seen previously. After removal of the endothelium the dilatory response was no longer observed. Mounting an intact vessel (A) proximal to the denuded vessel (B) produced an ACh-induced dilation of both segments when the perfusate flowed from the intact artery to the denuded one. . Bar graph summarizing membrane potential (E^ data in pressurized rat femoral arterial segments. Vessels were studied before and after endothelium removal with collagenase. "Control" perfusion solution was physiological saline solution (PSS). All cells depolarized to 5xl0~6 M norepinephrine (NE). When 5xlO' 6 M acetylcholine (NE+Ach) was added to the perfusate when the endothelium was intact, the cells hyperpolanzed from -35±1.2 to -66±2.0mV. When acetylcholine was perfused through preparations in which the endothelium was removed, there was no significant change in £". The vertical lines through each bar represent the ±SEM of the number of impalements. Significance (p<0.001) is represented by the asterisk. At least 12 cells were studied in at least five preparations for each point. . Bar graph of data obtained using the doubleperfused bioassay preparations, which summarizes the diameter response to acetylchoUne (ACh) perfusion in norepinephrine (NE) precontracted femoral arteries. First two bars (left to right) represent the control response to acetylchoUne (5xlO~6 M) in precontracted vessels with an intact endotheUum. Second two bars represent the acetylchoUne response in vessels that were denuded of endothelium. Last bar demonstrates the acetylchoUne response of the same denuded vessel when an intact segment was placed proximal to it. The data shows that the denuded "B" vessel regained the ability to dilate on acetylchoUne administration receiving theperfusate from the intact "A" one. Seven vessels were studied for each data point. The vertical line through each bar represents the ±SEM. femoral artery (A), ACh hyperpolarized the recipient vessel to the same extent as the intact donor.
Bioassay of EDRF in Rat Femoral Arteries Connected in Series
To further confirm that this phenomenon is a result of the EDRF release from the segment with an intact endothelium, the flow of the perfusate was reversed. Only the intact vessel demonstrated significant hyperpolarization, when the flow was reversed ( Figure 6A ).
Effect of [K + ] o and Tetraethylammoniwn on ACh-Induced Hyperpolarization
To clarify the ionic mechanism of action of AChliberated EDRF on arterial smooth muscle hyperpolarization, the membrane depolarizing effect of increasing [K + ] o was examined. Figure 7 shows the relation between En, and log [K" 1 "]^ Regression curves were calculated from the data obtained at between 8 and 120 mM [K + ] o . For ACh-perfused arterial segments having an intact endothelium, the average change in E m for a 10-fold change in [K + ] o (10-100 mM) was 50 mV/decade with an x-intercept to an intracellular potassium concentration of 145 mM. When the endothelium was removed before ACh perfusion, this difference fell to 39 mV (different at /?<0.05) with an ^-intercept to [K + ] o of 167 mM. Table 1 lists the E,,, and the sodium to potassium permeability (P N ./PK) ratio values calculated from the above data using the Goldman constant-field equation (given below) assuming an intracellular sodium concentration ([Na"1"],) of 15 mM and a passive chloride distribution. The P^/P i c ratio of the denuded vessel was twice that of the intact arterial segment.
To further examine the role of g K changes in EDRF-induced hyperpolarization, a potassium channel blocker, TEA, was added to the superfusate. TEA markedly reduced the hyperpolarization by ACh-induced EDRF on NE pretreated arterial segments (Figure 8 ).
Discussion
These data demonstrate that ACh liberates a substance from an intact pressurized arterial segment that affects a deendothelialized segment in a manner that is statistically identical to its intact counterpart. The inhibition of dilation and hyperpolarization to ACh on endothelial removal demonstrates that these actions are mediated by endothelium-derived substances, namely EDRF. There are other reports that EDRF liberated from intact arterial ring segment has an action on a deendothelialized vessel. 11 -13 However, our system uses donor and recipient cylindrical vessel segments from the same animal, which are pressurized at a normal mean arterial pressure (100 mm Hg). Also, since the short distance between donor and recipient vessels allows transport of the EDRF before tnactivation, the experimental design used in the present study permits electrical and mechanical measurements to be performed simultaneously on either vessel.
The hyperpolarization by ACh-induced release of EDRF confirms previous reports of others in rabbit saphenous arteries 7 and in coronary arteries 8 ; however, the magnitude of the response in femoral arteries was somewhat greater. The fact that much of the hyperpolarization was blocked by the K + channel blocker TEA suggests that such hyperpolarization is mediated largely by an increase of g K -Interpretation of the mechanism of action of EDRF response. The finding that with an intact endothelium ACh significantly hyperpolarizes the muscle cells and enhances the AE^ for a 10-fold difference in [K + ] o (between 10-100 mM), together with the data obtained in the presence of TEA, strongly suggests that the hyperpolarizing action of EDRF is mediated, at least partly, by an increase in g K . The relation between E m and [ K ] o is determined largely by the relative permeability of Na 1 4 and K (P N ,/P K ratio). An increase can result from either a reduction in P N , or an increase in P K . While we cannot absolutely differentiate between these two mechanisms using the present techniques (voltage clamping is required), the inhibitory action of TEA strongly supports the hypothesis for an EDRF-induced elevation of g K .
Our finding that a hyperpolarization is always accompanied by a dilation demonstrates that EDRF is acting through an "electromechanical coupling" process. While the ACh-induced hyperpolarization can be attributed to an elevated g^ other mechanisms, namely, stimulation of Na,K-ATPase could also account for some of this action. Indeed, Feletou and Vanhoutte suggest such a mechanism. It is possible that part of the hyperpolarization we observed to ACh is due to stimulation of Na,K-ATPase activity. However, the magnitude of our response (up to 31 mV) and the other data presented above suggests that a large part of the hyperpolarization is mediated by an elevation of g K . The maximum depolarization usually observed on inhibition of electrogenic Na-K transport in arterial muscle is 10-15 mV.
It is also possible that the elevation in cyclic GMP reported in response to EDRF 15 -17 may directly modify vascular smooth muscle membrane ionic conductances and/or pump mechanisms. It has been reported recently that elevation in cyclic GMP can activate Na-K-Cl cotransport in vascular muscle. 18 Therefore, it is not yet possible to determine if an EDRF-induced change in K + conductance is primary or secondary or independent to the generation of intracellular second messengers.
In summary, EDRF released by ACh administration significantly hyperpolarized and relaxed vascular smooth muscle in isolated perfused segments of femoral artery. This hyperpolarization was mediated, at least partly, by an increase in g K . From these observations, we conclude that the pressurized arterial bioassay preparation described here provides a valuable tool for studying the mechanism of EDRF.
